Th1 cytokines are upregulated by adenoviral vectors in the brains of primed mice

NeuroReport

Volumn 19, Issue 12, 2008, Pages 1187-1192

  Lee, Marco B ^a   McMenamin, Margaret Mary ^a,b   Byrnes, Andrew P ^a   Charlton, Harry M ^a   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytokines; Demyelination; Dopamine transporter; Gene therapy; Interferon g; Primed animals; Th1; Th2; Tumour necrosis factor

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; DOPAMINE TRANSPORTER; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN E1; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOREGULATION; INFLAMMATION; LACTOSE OPERON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; REPORTER GENE; TH1 CELL; TH2 CELL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ATADENOVIRUS; C3H MOUSE; CYTOLOGY; GENE VECTOR; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE STRAIN; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ATADENOVIRUS; BETA-GALACTOSIDASE; BRAIN; CYTOKINES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED C3H; MICE, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 51649087236     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283088e3d     Document Type: Article

References (26)

1. Byrnes AP, MacLaren RE, Charlton HM. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci 1996; 16:3045-3055.
2. Cartmell T, Southgate T, Rees GS, Castro MG, Lowenstein PR, Luheshi GN. Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J Neurosci 1999; 19:1517-1523.
3. Lowenstein PR, Castro MG. Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences. Gene Ther 2003; 10:946-954.
4. Lowenstein PR, Mandel RJ, Xiong WD, Kroeger K, Castro MG. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. Curr Gene Ther 2007; 7:347-360.
5. Wood MJ, Charlton HM, Wood KJ, Kajiwara K, Byrnes AP. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci 1996; 19:497-501.
6. Bruder JT, Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 1997; 71:398-404.
7. Thomas CE, Schiedner G, Kochanek S, Castro MG, Lowenstein PR. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proc Natl Acad Sci U S A 2000; 97:7482-7487.
8. Thomas CE, Schiedner G, Kochanek S, Castro MG, Lowenstein PR. Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors. Hum Gene Ther 2001; 12:839-846.
9. Byrnes AP, Wood MJ, Charlton HM. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther 1996; 3:644-651.
10. Shenk T. The viruses and their replication. In: Fields B, Knipe DM, Howley PM, editors. Fundamental virology. Philadelphia: Lippincott-Raven; 1996.
11. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-146.
12. Regardsoe EL, McMenamin MM, Charlton HM, Wood MJ. Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS. Gene Ther 2004; 11:1462-1474.
13. Byrnes AP, Rusby JE, Wood MJ, Charlton HM. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 1995; 66:1015-1024.
14. Wood MJ, Byrnes AP, Pfaff DW, Rabkin SD, Charlton HM. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther 1994; 1:283-291.
15. McMenamin MM, Lantos T, Carter EE, Hamilton L, Charlton HM, Gonzalez SC, et al. Neuropathological consequences of delivering an adenoviral vector in the rat brain. J Gene Med 2004; 6:740-750.
16. Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends Pharmacol Sci 1999; 20:424-429.
17. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69:2004-2015.
18. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994; 91:4407-4411.
19. Ijzermans JN, Marquet RL. Interferon-gamma: a review. Immunobiology 1989; 179:456-473.
20. Ruddle NH. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opin Immunol 1992; 4:327-332.
21. Gonzalez SC, McMenamin MM, Charlton HM, Goodman J, Lantos T, Simpson C, et al. Readministration of adenoviral gene delivery to dopamine neurons. Neuroreport 2007; 18:1609-1614.
22. Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 1997; 8: 2019-2029.
23. Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 2006; 6:52-68.
24. Quinones MP, Kalkonde Y, Estrada CA, Jimenez F, Ramirez R, Mahimainathan L, et al. Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt. Mol Cell Neurosci 2008; 37:96-109.
25. Onoe K, Yanagawa Y, Minami K, Iijima N, Iwabuchi K. Th1 or Th2 balance regulated by interaction between dendritic cells and NKT cells. Immunol Res 2007; 38:319-332.
26. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994; 180:1961-1966.